AHCC Could Show a Reduction in Symptoms and Side Effects for Chronic Diseases
- Data from the American Diabetes Association in 2011 reported that 25.8 million children and adults in the United States, have diabetes.
- An additional 79 million have pre-diabetes (meaning they are likely to develop the disease within a few years).
- Each year 1.9 million new cases of diabetes are diagnosed in people aged 20 and older.
- In 2010 the CDC forecasted that as many as one in three people in the United States could have diabetes by 2050.
- AHCC has anti-inflammatory properties, so scientists have explored its use in animal models of diabetes.
- Turn to page 56 of Chapter 6: Other Chronic Diseases to learn about a recent study conducted at Dokkyo University School of Medicine in Saitama, Japan and a study conducted by researchers at Osaka University in Osaka, Japan comparing the treatment of rats with diabetes.
- As well, be sure to read about the study conducted by Dr. M. Iwamoto of Nobuyana Medical Corporation that involved 13 diabetic patients. In brief, all the individuals in the study took AHCC for more than six months and experienced significant declines in both average blood glucose levels and glycohemoglobin.
- Acute liver failure is an uncommon but serious condition that has a high mortality rate.
- Hepatitis is an inflammation of the liver and also refers to a group of viruses that affect the organ.
- According to the CDC, in 2008, an estimated 4.4 million Americans were living with chronic hepatitis and approximately 80,000 new infections occur annually in the United States.